These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26509663)

  • 1. Effect of allergen-specific immunotherapy on CD4+ T cells.
    Wambre E
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):581-7. PubMed ID: 26509663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of regulatory B cells in allergen immunotherapy.
    van de Veen W
    Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):447-452. PubMed ID: 28957824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen immunotherapy and tolerance.
    Matsuoka T; Shamji MH; Durham SR
    Allergol Int; 2013 Dec; 62(4):403-13. PubMed ID: 24280670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.
    Kappen JH; Durham SR; Veen HI; Shamji MH
    Ther Adv Respir Dis; 2017 Jan; 11(1):73-86. PubMed ID: 27678500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy.
    Gueguen C; Bouley J; Moussu H; Luce S; Duchateau M; Chamot-Rooke J; Pallardy M; Lombardi V; Nony E; Baron-Bodo V; Mascarell L; Moingeon P
    J Allergy Clin Immunol; 2016 Feb; 137(2):545-58. PubMed ID: 26522402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.
    Palomares O; Akdis M; Martín-Fontecha M; Akdis CA
    Immunol Rev; 2017 Jul; 278(1):219-236. PubMed ID: 28658547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased inhibitory surface marker PD-1 expression in CD4
    Jie X; Wang D; Da H; Li H; Zhao H; He J; Liu J; Ma Y; Qiang Z; Li Z; Zhong H; Liu Y
    Immunobiology; 2024 Jul; 229(4):152824. PubMed ID: 38875763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of allergen immunotherapy.
    Şahin E; Bafaqeeh SA; Güven SG; Çetinkaya EA; Muluk NB; Coşkun ZO; Lopatin A; Kar M; Pinarbasli MO; Cingi C
    Am J Rhinol Allergy; 2016 Sep; 30(5):1-3. PubMed ID: 27658024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific foundations of allergen-specific immunotherapy for allergic disease.
    Soyka MB; van de Veen W; Holzmann D; Akdis M; Akdis CA
    Chest; 2014 Nov; 146(5):1347-1357. PubMed ID: 25367471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
    Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
    Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
    Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance mechanisms in allergen immunotherapy.
    Celebi Sözener Z; Mungan D; Cevhertas L; Ogulur I; Akdis M; Akdis C
    Curr Opin Allergy Clin Immunol; 2020 Dec; 20(6):591-601. PubMed ID: 33002895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
    Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
    J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immune responses by immunotherapy in allergic diseases.
    Cavkaytar O; Akdis CA; Akdis M
    Curr Opin Pharmacol; 2014 Aug; 17():30-7. PubMed ID: 25062122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.
    Saint-Lu N; Tourdot S; Razafindratsita A; Mascarell L; Berjont N; Chabre H; Louise A; Van Overtvelt L; Moingeon P
    Allergy; 2009 Jul; 64(7):1003-13. PubMed ID: 19220212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.